Table 2. Major adverse cardiac events (MACE) between the rhBNP and control groups.
| MACE | rhBNP group (n=135) | Control group (n=136) | χ2 | P |
|---|---|---|---|---|
| Total | 19 (14.07) | 60 (44.12) | 7.749 | 0.005 |
| Acute left heart failure | 8 (5.93) | 23 (16.91) | 6.129 | 0.019 |
| Acute myocardial infarction | 4 (2.96) | 7 (5.15) | 3.319 | 0.100 |
| Malignant arrhythmia | 6 (4.44) | 27 (19.85) | 4.022 | 0.021 |
| Sudden cardiac death | 1 (0.74) | 3 (2.21) | 2.986 | 0.250 |
Data are n (%), unless otherwise specified. rhBNP, recombinant human brain natriuretic peptide.